DCM
ANIP icon

Driehaus Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Driehaus Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
121,852
+393
+0.3% +$31.5K 0.06% 278
2026
Q1 		$9.34M Buy
121,459
+45,279
+59% +$3.53M 0.07% 272
2025
Q4 		$6.01M Sell
76,180
-2,634
-3% -$228K 0.04% 299
2025
Q3 		$7.22M Buy
+78,814
New +$6.43M 0.05% 307
2018
Q1 		– Sell
-3,414
Closed -$220K – 489
2017
Q4 		$220K Buy
+3,414
New +$212K 0.01% 503
2016
Q4 		– Sell
-3,160
Closed -$210K – 526
2016
Q3 		$210K Buy
+3,160
New +$198K 0.01% 474
2015
Q2 		– Sell
-57,123
Closed -$3.57M – 516
2015
Q1 		$3.57M Buy
57,123
+14,505
+34% +$882K 0.12% 205
2014
Q4 		$2.4M Sell
42,618
-121,269
-74% -$5.35M 0.1% 272
2014
Q3 		$4.63M Sell
163,887
-65,832
-29% -$1.97M 0.18% 161
2014
Q2 		$7.91M Buy
229,719
+96,203
+72% +$3.02M 0.26% 98
2014
Q1 		$4.19M Buy
+133,516
New +$3.54M 0.13% 197

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Driehaus Capital Management's ANIP Position: Q2 2026 in Review

Driehaus Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 0.32% in Q2 2026, buying an estimated $31.5K and bringing the position to 121,852 shares worth $10.1M. The position accounts for 0.06% of the portfolio, ranked #278.

Driehaus Capital Management first reported a position in ANIP in Q1 2014 and has held it in 11 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Driehaus Capital Management held 121,852 shares of ANI Pharmaceuticals worth $10.1M as of Q2 2026.
  • Driehaus Capital Management bought 393 ANI Pharmaceuticals shares in Q2 2026, an estimated $31.5K.
  • ANI Pharmaceuticals made up 0.06% of Driehaus Capital Management's portfolio in Q2 2026, its #278 holding.
  • Driehaus Capital Management first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 11 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.